11. Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program. Issue 8 (15th May 2016) Authors: Jendle, Johan; Grunberger, George; Blevins, Thomas; Giorgino, Francesco; Hietpas, Ryan T.; Botros, Fady T. Journal: Diabetes/metabolism research and reviews Issue: Volume 32:Issue 8(2016:Nov.) Page Start: 776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. Estimating the impact of changes in HbA1c, body weight and insulin injection regimen on health related quality-of-life: a time trade off study. Issue 1 (December 2016) Authors: Ridderstråle, Martin; Evans, Lyndon; Jensen, Henrik; Bøgelund, Mette; Jensen, Marie; Ericsson, Åsa; Jendle, Johan Journal: Health and quality of life outcomes Issue: Volume 14:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. Heart rate variability in type 2 diabetic subjects randomized to liraglutide or glimepiride treatment, both in combination with metformin: A randomized, open, parallel‐group study. Issue 2 (6th February 2019) Authors: Nyström, Thomas; Santos‐Pardo, Irene; Fang, Xin; Cao, Yang; Hedberg, Fredric; Jendle, Johan Journal: Endocrinology, diabetes & metabolism Issue: Volume 2:Issue 2(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. Improved treatment satisfaction in patients with type 2 diabetes treated with once‐weekly semaglutide in the SUSTAIN trials. Issue 10 (12th July 2019) Authors: Jendle, Johan; Birkenfeld, Andreas L.; Polonsky, William H.; Silver, Robert; Uusinarkaus, Kari; Hansen, Thomas; Håkan‐Bloch, Jonas; Tadayon, Sayeh; Davies, Melanie J. Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 10(2019) Page Start: 2315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18 168 people with type 1 diabetes: observational study. (22nd June 2015) Authors: Steineck, Isabelle; Cederholm, Jan; Eliasson, Björn; Rawshani, Araz; Eeg-Olofsson, Katarina; Svensson, Ann-Marie; Zethelius, Björn; Avdic, Tarik; Landin-Olsson, Mona; Jendle, Johan; Gudbjörnsdóttir, Soffia Journal: BMJ Issue: Volume 350(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. Model‐based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease. Issue 3 (2nd December 2022) Authors: Nilsson, Kristoffer; Andersson, Emelie; Persson, Sofie; Karlsdotter, Kristina; Skogsberg, Josefin; Gustavsson, Staffan; Jendle, Johan; Steen Carlsson, Katarina Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 3(2023) Page Start: 748 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study. Issue 9982 (23rd May 2015) Authors: Blonde, Lawrence; Jendle, Johan; Gross, Jorge; Woo, Vincent; Jiang, Honghua; Fahrbach, Jessie L; Milicevic, Zvonko Journal: Lancet Issue: Volume 385:Issue 9982(2015) Page Start: 2057 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. Pilots and Diabetes Technology: Functional Health. (March 2017) Authors: Jendle, Johan; Rinnert, Kurt; Westman, Anton; Heinemann, Lutz Journal: Journal of diabetes science and technology Issue: Volume 11:Number 2(2017:Mar.) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. Real-world cost-effectiveness of insulin degludec in type 1 and type 2 diabetes mellitus from a Swedish 1-year and long-term perspective. (1st November 2020) Authors: Jendle, Johan; Ericsson, Åsa; Ekman, Bertil; Sjöberg, Stefan; Gundgaard, Jens; da Rocha Fernandes, João; Mårdby, Ann-Charlotte; Hunt, Barnaby; Malkin, Samuel J. P.; Thunander, Maria Journal: Journal of medical economics Issue: Volume 23:Number 11(2020) Page Start: 1311 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. Real‐world performance of the MiniMed™ 670G system in Europe. Issue 8 (27th May 2021) Authors: Da Silva, Julien; Bosi, Emanuele; Jendle, Johan; Arrieta, Arcelia; Castaneda, Javier; Grossman, Benyamin; Cordero, Toni L.; Shin, John; Cohen, Ohad Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 8(2021) Page Start: 1942 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗